May 13, 2021
Business News

Dicerna to Participate in the Chardan 4th Annual Genetic Medicines Conference


LEXINGTON, Mass.–()–Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA), a leading developer of investigational ribonucleic acid interference (RNAi) therapeutics, today announced that Douglas M. Fambrough, Ph.D., president and chief executive officer, will participate in a virtual fireside chat at the Chardan 4th Annual Genetic Medicines Conference on Mon., Oct. 5, 2020 at 1:30 p.m. ET.

A live audio webcast of the event will be accessible from the Investors and Media section of the Dicerna website at www.investors.dicerna.com. An archived replay will be available on the Company’s website following the event.

About Dicerna Pharmaceuticals, Inc.

Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA) is a biopharmaceutical…



Click here to view the original article.

Related Posts

You might also like ...

AON Splash Image
Finance of America Reports First Quarter 2021 Results
Farmers Edge Reports First Quarter 2021 Results
U.S. Department of Health and Human Services Selects Box for Cloud Content Management